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Abstract 
Background: Children with severe malaria are at increased risk of invasive bacterial disease particularly infection 
with enteric gram‑negative organisms. These organisms are likely to originate from the gut, however, how and 
why they breach the intestinal interface in the context of malaria infection remains unclear. One explanation is that 
accumulation of infected red blood cells (iRBCs) in the intestinal microvasculature contributes to tissue damage and 
subsequent microbial translocation which can be addressed through investigation of the impact of cytoadhesion in 
patients with malaria and intestinal damage.
Methods: Using a static adhesion assay, cytoadhesion of iRBCs was quantified in 48 children with malaria to recom‑
binant proteins constitutively expressed on endothelial cell surfaces. Cytoadhesive phenotypes between children 
with and without biochemical evidence of intestinal damage [defined as endotoxemia or elevated plasma intestinal 
fatty acid binding protein (I‑FABP)] was compared.
Results: The majority of parasites demonstrated binding to the endothelial receptors CD36 and to a lesser extent to 
ICAM‑1. Reduced adhesion to CD36 but not adhesion to ICAM‑1 or rosetting was associated with malarial anaemia 
(p = 0.004). Increased adhesion of iRBCs to ICAM‑1 in children who had evidence of elevated I‑FABP (p = 0.022), a 
marker of intestinal ischaemia was observed. There was no correlation between the presence of endotoxemia and 
increased adhesion to any of the recombinant proteins.
Conclusion: Increased parasite adhesion to ICAM‑1 in children with evidence of intestinal ischaemia lends further 
evidence to a link between the cytoadherence of iRBCs in gut microvasculature and intestinal damage.
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Background
Children with severe Plasmodium falciparum malaria 
are at increased risk of concomitant invasive bacterial 
infection (IBI) particularly with enteric gram-negative 
organisms (EGNOs) [1]. In a systematic review compil-
ing data from epidemiological studies and clinical studies 
of paediatric hospital admissions of P. falciparum malaria 
(describing IBI) across sub-Saharan Africa, the mean 
prevalence of IBI co-infection was 6.4  % (95  % CI 5.81 
−6.98  %). Bacterial co-infection results in higher case 
fatalities compared to children with severe malaria alone 
(24.1 versus 10.2 %). An estimated one-third of all severe 
malaria deaths in African children are attributable to bac-
terial co-infection [2]. The precise mechanism by which 
children with malaria are predisposed to bacteraemia are 
uncertain and is a major limitation in the development of 
new strategies to reduce morbidity and mortality in this 
disease.
The preponderance of gram-negative bacteraemias, 
including non-typhoidal salmonellae and Escherichia coli, 
in children with malaria is highly suggestive of an intestinal 
process involving translocation of intraluminal microbes 
across a compromised gut barrier. There is patchy evi-
dence, which attests to gut barrier damage in malaria 
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disease. Adults with acute malaria have reduced absorptive 
capacity as well as increased intestinal permeability meas-
ured using a differential sugar absorption test, the highest 
ratios being noted in severe disease [3]. Up to 50 % of Nige-
rian infants with uncomplicated malaria have gastrointes-
tinal disturbances [4]. In addition, we previously showed 
that approximately 30 % of children admitted to hospital 
with malaria suffered from endotoxemia [5]. Endotoxin, a 
complex lipopolysaccharide (LPS), which is constituent in 
the cell walls of gram-negative bacteria, has been used in a 
variety of cohorts as a measure of microbial translocation 
[6, 7]. In 59 (29 %) children, raised plasma concentration of 
intestinal fatty acid binding protein (I-FABP), a marker of 
acute gut injury, were detected although elevated I-FABP 
and endotoxemia were not associated.
There are several mechanisms, not necessarily mutu-
ally exclusive, that might impair gut barrier integrity and 
function in children with malaria. Firstly, hypoperfusion 
may occur in the context of severe malarial anaemia and 
shock; the resulting hypoxic damage to the intestinal epi-
thelium can lead to increased permeability with subse-
quent translocation of intestinal contents [8]. Secondly 
systemic inflammation, which accompanies sepsis as 
well as severe forms of P. falciparum malaria, can result 
in increased intestinal permeability even in the absence 
of enterocyte damage [9]. This may in part be mediated 
by l-arginine deficiency, a hallmark of malaria parasite 
infection, which has been shown to potentiate intesti-
nal inflammation and permeability in mice [10]. Thirdly, 
an important factor in the pathogenesis of P. falciparum 
malaria is thought to be the adherence of infected red 
blood cells (iRBCs) to receptors on small vessel endothe-
lial cells. The resultant sequestration of iRBCs in specific 
organs is most notable in the case of cerebral malaria 
where iRBCs accumulate in brain microvasculature. 
Moreover, findings from histopathological sections taken 
at autopsy from children who died of severe malaria sug-
gest that intense sequestration is also manifest in the 
gut [11, 12]. The accumulation of iRBCs in the intestinal 
microvasculature is, therefore, another possible cause of 
tissue damage leading to microbial translocation.
To further explore the contribution of parasite seques-
tration to microbial translocation in the gut, parasite 
adhesion in children with both malaria and endotoxemia 
or acute gut injury was assessed. Adhesion was quanti-
fied in vitro by measuring rosetting of iRBCs with unin-
fected erythrocytes as well as their binding to receptors 
constitutively expressed on endothelial cell surfaces.
Methods
Study population
The study population has been described in detail else-
where [5]. In brief, 257 children admitted to Mbale 
Regional Referral Hospital in Uganda with a diagno-
sis of malaria were recruited into the study. Based on 
severity of clinical symptoms, children were classified 
into those hospitalized with malaria (positive blood 
film and rapid diagnostic test) but without life-threat-
ening clinical syndromes and those with severe malaria 
and at least one life-threatening clinical syndrome (Hb 
≤5  dg/ml; impaired consciousness defined as prostra-
tion on clinical examination or coma; deep breathing) 
according to recruitment criteria for the FEAST trial 
(ISRCTN69856593) ongoing at that time [13]. A propor-
tion of these children with severe malaria and signs of 
a life-threatening syndrome also had signs of impaired 
perfusion (defined as a capillary refill time of 3 or more 
seconds, lower-limb temperature gradient, weak radial-
pulse volume, or severe tachycardia), and were recruited 
into the FEAST trial [13]. On admission, a 5 ml venous 
blood sample was taken and PBMCs, RBCs and plasma 
separated and stored at minus 80 °C.
The study was approved by the Ugandan Ethical Review 
Committee (REIRC 002/2009). Written informed con-
sent was provided by all parents or guardians of children 
recruited into the study.
Elisa
The plasma concentrations of TNF (R&D Systems, Inc.) 
and I-FABP (Hyglos GmbH) were determined using 
ELISA according to the manufacturer’s recommendations.
EAA assay
An endotoxin activity assay, EAA™ (Spectral Diagnos-
tics Inc, Toronto, Canada) was used to quantify endo-
toxin levels in EDTA blood, carried out within 3  h of 
venepuncture according to the manufacturer’s recom-
mendation. A cut off value of 0.4 EAA units for clini-
cally relevant endotoxemia was used, as evaluated in the 
MEDIC trial [6].
Static adhesion assay and rosetting
Samples were blinded and remained so until all the data 
had been collected and analysed. RBCs were thawed 
and P. falciparum iRBCs cultured to maturity accord-
ing to standard procedures [14]. Mature trophozoite 
stages were observed after a median time of 30 h (range 
26–50  h). Cultures with a parasitaemia above 0.5  % 
were included and those with greater than 3  % parasi-
taemia were diluted down to 3  % (median parasitaemia 
1  %, range 0.5–4.7  %). The laboratory line ITG selected 
for adhesion to ICAM-1, was used as a positive control 
for each experiment. When most of the parasites had 
reached the pigmented trophozoite stage, the culture was 
harvested and washed twice in binding medium (RPMI 
1640 with 20 mM Hepes).
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Recombinant ICAM-1-Fc (donated by Alister Craig’s 
laboratory) and CD36-Fc (R&D Systems Inc.) have been 
used before in static adhesion assays. Two less recognized 
proteins, fractalkine and MadCAM (R&D systems, Inc.) 
were included, both of which are implicated in intes-
tinal pathology. Fractalkine expression is enhanced in 
inflammatory Crohn’s disease lesions [15] and MadCAM, 
expressed on the surface of high endothelial venules in 
the gut, is the ligand for the integrin α4β7 allowing lym-
phocyte homing to the gut [16]. Recombinant proteins 
were spotted in triplicate onto two plastic petri dishes 
at a concentration of 50 μg/ml. Plates were blocked with 
3 % BSA, washed and parasite suspension added for 1 h 
at 37  °C with gentle rotation every 10  min. Unbound 
parasites were washed off, adhering parasites fixed with 
1 % glutaraldehyde followed by staining with 1 % Giemsa 
in PBS. Images were taken using direct microscopy by 
Image-Pro Analyser and adhering parasites counted 
using QCapture Pro (QImaging) software. Results are 
presented as the mean number of parasites/mm2 protein 
adjusted to 3 % parasitaemia.
For the rosetting assay, 20  μl of parasite suspension 
in binding medium containing 5  μg/ml acridine orange 
(Sigma–Aldrich) and 20  % AB serum was rotated for 
30 min at room temperature. The rosetting frequency of 
each isolate was scored by determining the percentage 
of 200 trophozoite-infected erythrocytes bound to two 
or more uninfected erythrocytes using a fluorescence 
microscope (Nikon eclipse 80i, Japan) [17].
Statistical analysis
Continuous variables were compared between groups 
using the Mann–Whitney U test or Kruskal–Wallis H 
test. Spearman’s rho correlation coefficient was used to 
determine a relationship between continuous variables. 
Statistical analyses were performed using Stata version 
12 (StataCorp LP).
Results
RBCs of 109 children hospitalized with P. falciparum 
malaria were cultured to allow iRBCs to grow to matu-
rity. Of the 109 isolates, iRBCs of 48 (44  %) samples 
grew to maturity. The high failure rate may be explained 
by the use of anti-malarials prior to hospital admission, 
which is commonplace in this region of Uganda. There 
was no significant difference with respect to haemato-
logical and clinical data between the two groups and, 
therefore, the samples evaluated for adhesion can be 
considered representative of the overall group of chil-
dren (Table 1). Of those children whose parasites grew 
in culture, 79.2  % (n =  38) had severe malaria defined 
clinically, with almost half (n  =  22) suffering from a 
degree of impaired conscious (prostration or coma), 
but only 8.3  % (n =  4) had unrousable coma (Blantyre 
coma score ≤2). In the children with viable parasites, 
the number of children with endotoxemia (EAA units 
≥0.4) was somewhat underrepresented in the group of 
children with available adhesion data (Chi squared 3.3, 
p = 0.067).
As previously described, the majority of parasites dem-
onstrated binding to the endothelial receptors CD36 
and to a lesser extent to ICAM-1 [14, 18]. There was no 
binding observed in any of the samples to fractalkine and 
MadCAM. There was a significant association between 
adhesion to CD36 and ICAM-1 (Spearman rho 0.34, 
p  =  0.017) however neither was correlated with roset-
ting (Spearman rho = 0.09 & 0.07; p = 0.53 and p = 0.64 
respectively). Reduced adhesion to CD36 but not adhe-
sion to ICAM-1 or rosetting was associated with malarial 
anaemia (Spearman rho = 0.41, p = 0.004) (Fig. 1). There 
was no relationship between binding to ICAM-1 and 
coma (p  =  0.65), however adhesion under static condi-
tions does not have the sensitivity to establish this rela-
tionship, which has been demonstrated in  vitro under 
flow [14].
Next, an association with adhesion of iRBCs with either 
marker of intestinal compromise was investigated: endo-
toxemia (EAA ≥0.4) and a marker of acute enterocyte 
damage (I-FABP ≥183 pg/ml plasma). Adhesion of iRBCs 
to CD36 and ICAM-1 as well as rosetting was similar in 
children with or without endotoxemia (Fig.  2). By con-
trast, adhesion of iRBCs to ICAM-1 but not CD36 or 
rosetting was significantly increased in children who had 
elevated plasma concentrations of I-FABP (Spearman 
rho =  0.36, p =  0.022) (Fig.  2). Samples with increased 
binding to ICAM-1 were also associated with elevated 
plasma concentrations of TNF (Spearman rho  =  0.30, 
p  =  0.038) particularly in children who also had raised 
levels of I-FABP (Spearman rho  =  0.62, p  =  0.055) 







Number of children 48 61
Median age (months) 25.5 (12–40) 26 (15–44)
Median haemoglobin 6.5 (4.3–9.5) 5.9 (3.8–9.3)
Severe malaria 38 (79.2 %) 49 (80.3 %)
Impaired consciousness 22 (45.8 %) 25 (37.3 %)
Coma 4 (8.3 %) 4 (6.5 %)
Severe anaemia 18 (37.5 %) 27 (44 %)
Respiratory distress 37 (77 %) 43 (70.5 %)
Endotoxemia (EAA ≥ 0.4 U) 16 (33 %) 31 (50.8 %)
I‑FABP ≥183 pg/ml 10 (20.8 %) 12 (19.6 %)
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although here the difference did not quite reach signifi-
cance (Fig. 3).
Discussion
In children with malaria and acute gut injury, adhe-
sion of mature iRBCs to ICAM-1 under static condi-
tions was significantly increased. These data suggest that 
acute enterocyte damage is associated with the binding 
of sequestered iRBCs to ICAM-1 expressed on the sur-
face of gut endothelial cells. Without a healthy enterocyte 
barrier, it follows that intestinal pathogens or their prod-
ucts such as endotoxin may pass unimpeded into the sys-
temic circulation further complicating malaria infection.
There is a well-established link between adhesion of 
iRBCs to ICAM-1 and cerebral malaria. Histological 
examination of brains of patients who died of cerebral 
malaria have shown that iRBCs co-localized with ICAM-1 
[19] and binding to ICAM-1 was higher in children with 















































Fig. 1 Adhesion of iRBC in children with impaired consciousness or 
anaemia. Shown are dot plots of the number of iRBCs/mm2 binding 
to CD36, ICAM‑1 or the percentage of iRBCs in rosettes with RBCs 
in children with (plus) or without (minus) impaired consciousness 
(prostration or coma) and in children with (plus) or without (minus) 
anaemia (Hb ≤ 7). Median and interquartile range are indicated, * 















































Fig. 2 Adhesion of iRBC in children with endotoxemia or increased 
plasma concentrations of I‑FABP. Shown are dot plots of the number 
of iRBCs/mm2 binding to CD36, ICAM‑1 or the percentage of iRBCs in 
rosettes with RBCs in children with (plus) or without (minus) endotox‑
emia and in children with (plus) or without (minus) increased plasma 
concentrations of I‑FABP (I‑FABP ≥ 183 ng/ml) indicating acute 
enterocyte damage. Median ans interquartile range are indicated, * 
denotes p value of <0.05 (Mann–Whitney U test)



















Fig. 3 Correlation between iRBC adhesion to ICAM‑1 and the 
plasma concentration of TNF. Shown is a scatter plot of iRBCs/mm2 
binding to ICAM1 and the plasma concentration of TNF (pg/ml). 
Values from children with increased plasma concentration of I‑FABP 
(I‑FABP ≥ 183 ng/ml) are indicated by an open circle and values of 
children with a plasma concentration below pathological levels 
(I‑FABP < 183 ng/ml) are indicated by black circles
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cerebral malaria, sequestration of iRBCs is high in the 
gut as well as the brain compared to children who died 
with parasitaemia and other infections [20]. Seques-
tration in both brain and gut tissue may, therefore, be 
driven by expression of ICAM-1. ICAM-1 is constitu-
tively expressed on endothelial cells in the gut microvas-
culature and neutrophils from blood of malaria patients 
cause endothelial damage in vitro by binding to ICAM-1 
[21]. However, it remains difficult to determine whether 
ICAM-1 expression is itself causative or merely a by-
product of local inflammation and an altered gastroin-
testinal barrier. Whilst ICAM-1 expression increases 
pro-inflammatory cytokines via adhesion of iRBCs [22], 
pro-inflammatory cytokines can also up regulate ICAM-1 
expression in the absence of parasite adhesion [23].
Overall, the data presented here correspond with other 
published studies on the binding of parasitized RBCs 
under static conditions [18]; the majority of iRBC isolates 
bound to CD36 and a lesser number to ICAM-1. Moreo-
ver the finding of reduced binding to CD36 in malarial 
anaemia was reproduced as described previously [18, 24].
This study is the first to examine in vitro the role of par-
asite adhesion in malaria subjects with evidence of intes-
tinal compromise. I-FABP, a small water-soluble protein 
present in mature enterocytes, is abundantly expressed 
on villous tips in the small intestine and is therefore a 
useful marker of acute enterocyte damage. It has been 
used to investigate intestinal damage in other cohorts 
including children undergoing surgery for congenital 
heart disease and neonates with suspected necrotis-
ing enterocolitis and meningococcal septicaemia where 
it can delineate between early sepsis and specific gut 
damage [25–27]. In this cohort, all infants were unwell 
enough to warrant admission to hospital with malaria. 
Almost 80 % had severe malaria and signs of at least one 
life threatening clinical syndrome attesting to the severity 
of disease. It is possible that the extent of intestinal dam-
age in this cohort was underestimated due to the short 
half-life of I-FABP. This may explain the lack of correla-
tion between endotoxemia and elevated I-FABP. In addi-
tion, although I-FABP does not provide a measure of 
microbial translocation, it may be a more specific marker 
of gut injury than endotoxin. Its relative abundance on 
villous tips is the same site where parasite sequestration 
has been observed to be most intense [11]. Furthermore, 
endotoxin levels can be difficult to accurately measure 
and can be elevated for a number of other reasons [28].
There were several limitations to this study. First, the 
high fall out rate when thawing and culturing iRBCs, 
comparable with other adhesion studies [14], halved the 
sample size. An important factor may have been the use 
of artemisinin-based combination anti-malarial therapies 
prior to hospital admission, indicating successful role out 
of the recent changes in first line management in Uganda, 
since their introduction in 2009—which will have impli-
cations for studies of fresh parasite isolates in future. 
Second, the case report form used in the FEAST trial did 
not document in detail clinical information regarding 
gastrointestinal symptoms and blood cultures were not 
routinely taken, which would have enhanced our defi-
nition and description of gastrointestinal compromise. 
Thirdly, the in vitro experiment lacked specificity to the 
gut. The attempt to introduce other gut specific recom-
binant proteins such as MadCAM was unsuccessful and, 
therefore, the study is based on the assumption that 
adhesion in the gut is similar to elsewhere in the body. 
Without a gut-specific model to assess adhesion in vitro 
to gut endothelium, it will be difficult to tease apart the 
precise contribution of iRBC-ICAM1 binding to intesti-
nal compromise in patients with malaria. This warrants 
further exploration.
These findings lend further evidence to a link between 
cytoadhesion and intestinal damage mediated by the 
sequestration of iRBCs in gut microvasculature. However 
there are other pathways that may also contribute to gas-
trointestinal damage in the context of malaria. Systemic 
inflammation, which is associated with severe disease, 
but also a hallmark of the sepsis syndrome can lead to 
gut epithelial cell damage [29]. The correlation between 
the pro-inflammatory cytokine TNF and elevated I-FABP 
levels which corroborates this [5]. In addition, malarial 
anaemia drives systemic inflammation but can also pre-
cipitate end organ damage via splanchnic hypoperfusion 
especially in combination with shock. However, an asso-
ciation between either anaemia or signs of hypoperfusion 
and markers of intestinal damage was not observed.
Conclusions
In conclusion, the increased parasite adhesion to 
ICAM-1 in children with evidence of intestinal damage is 
an important finding, which highlights the complex aeti-
ology behind increased susceptibility to gram-negative 
bacteraemia in children with malaria. Further research 
is required to unpick the relative contribution of iRBC 
sequestration and ICAM-1 binding towards gut barrier 
compromise. Only then the precise sequence of events in 
the pathogenesis of malaria-IBI co-infection and progress 
towards adjunctive therapies including antibiotics can be 
understood.
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